Tanvex BioPharma Market Cap

Tanvex BioPharma has a market cap or net worth of 13.12 billion as of May 13, 2025. Its market cap has increased by 64.44% in one year.

Market Cap

13.12B

Enterprise Value

13.81B

Revenue

81.18M

Ranking

n/a

PE Ratio

n/a

Stock Price

56.20

Market Cap Chart

Since August 13, 2015, Tanvex BioPharma's market cap has decreased from 16.77B to 13.12B, a decrease of -21.78%. That is a compound annual growth rate of -2.49%.

Market Cap History

Date	Market Cap	% Change
May 13, 2025	13.12B	22.62%
Dec 31, 2024	10.70B	22.75%
Dec 29, 2023	8.71B	-29.59%
Dec 30, 2022	12.38B	-39.56%
Dec 30, 2021	20.48B	106.96%
Dec 31, 2020	9.89B	-9.41%
Dec 31, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
PharmaEssentia	171.52B
Caliway Biopharmaceuticals	110.55B
Bora Pharmaceuticals Co., LTD.	74.21B
Lotus Pharmaceutical	60.03B
Polaris Group	33.16B
Oneness Biotech	28.27B
Pegavision	26.95B
Lumosa Therapeutics	26.52B

Market Cap Rankings